Skip to content
healthcare.dev

Mold Relief Formula

NDC 59623-013, Kali Muriaticum, Gelsemium, Kali Bichromicum, Sabadilla, Histaminum, Mold Mix., liquid, from Integrative Healing Institute, LLC.

Product NDC
59623-013
Status
Listed
Labeler
Integrative Healing Institute, LLC
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59623-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CHLORIDE6 [hp_X]/mL
  • GELSEMIUM SEMPERVIRENS ROOT12 [hp_C]/mL
  • POTASSIUM DICHROMATE12 [hp_C]/mL
  • SCHOENOCAULON OFFICINALE SEED12 [hp_C]/mL
  • HISTAMINE DIHYDROCHLORIDE30 [hp_C]/mL
  • ALTERNARIA ALTERNATA12 [hp_X]/mL
  • ASPERGILLUS FUMIGATUS12 [hp_X]/mL
  • ASPERGILLUS NIGER VAR. NIGER12 [hp_X]/mL
  • BOLETUS SATANAS FRUITING BODY12 [hp_X]/mL
  • BOTRYTIS CINEREA12 [hp_X]/mL
  • CANDIDA ALBICANS12 [hp_X]/mL
  • PASSALORA FULVA12 [hp_X]/mL
  • FUSARIUM OXYSPORUM12 [hp_X]/mL
  • COCHLIOBOLUS SATIVUS12 [hp_X]/mL
  • RHIZOPUS STOLONIFER12 [hp_X]/mL
  • AUREOBASIDIUM PULLULANS VAR. PULLUTANS12 [hp_X]/mL
  • USTILAGO MAYDIS12 [hp_X]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
59623-013-015962300130130 mL in 1 BOTTLE, DROPPER (59623-013-01)
59623-013-025962300130259 mL in 1 BOTTLE, DROPPER (59623-013-02)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 59623-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59623-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59623-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.